Zacks Investment Research
Abbott (ABT) Misses Q3 Earnings Estimates
Abbott reported Q3 2026 earnings of $1.42 per share, missing the consensus estimate of $1.43, though revenues of $13.01 billion exceeded expectations. The company has underperformed the S&P 500 by 18.2% year-to-date.
Despite the earnings miss, Abbott maintains a Zacks Rank #2 (Buy) rating based on favorable estimate revision trends. The Medical-Products industry ranks in the bottom 36% of Zacks industries.
